What is Leflunomide?
Leflunomide, sold under the brand name Arava, is a disease-modifying antirheumatic drug (DMARD) used primarily to treat rheumatoid arthritis (RA) and psoriatic arthritis [1.4.3, 1.4.6]. It works by suppressing the immune system to reduce inflammation, which in turn helps to decrease pain, swelling, and joint damage [1.3.2, 1.4.4]. Leflunomide is an immunomodulatory agent that inhibits an enzyme called dihydroorotate dehydrogenase, a key step in pyrimidine synthesis. This action hampers the proliferation of activated T-cells, which are crucial drivers of the autoimmune response in RA [1.2.2, 1.4.5].
The Link Between Leflunomide and Diarrhea
Diarrhea is not just a possible side effect of leflunomide; it is the most common one reported [1.2.4]. Studies show that between 17% and 27% of users experience it [1.2.1, 1.2.3].
Acute vs. Chronic Diarrhea
For many patients, the diarrhea is acute, typically starting within the first few weeks of treatment. This initial phase is often transient and may resolve on its own as the body adjusts to the medication [1.2.2, 1.3.6].
However, for some individuals, the diarrhea can be more persistent or even chronic. In rare instances, long-term leflunomide use can lead to more serious gastrointestinal issues, including different forms of colitis (inflammation of the colon), such as microscopic colitis, collagenous colitis, or lymphocytic colitis [1.2.1, 1.2.7]. The onset of leflunomide-induced colitis can be delayed, sometimes appearing months or even years after starting the medication [1.2.1, 1.2.2].
Why Does It Happen?
While the exact mechanism for leflunomide-induced diarrhea isn't fully understood, it is related to how the drug works and is processed in the gastrointestinal tract [1.3.6]. Leflunomide is a prodrug that is converted into its active metabolite, A77 1726 (also known as teriflunomide), within the intestinal mucosa and plasma [1.2.2]. This process and the drug's effect on rapidly dividing cells, including those in the gut lining, can lead to gastrointestinal upset.
Managing Leflunomide-Induced Diarrhea
If you experience diarrhea while taking leflunomide, it's essential to communicate with your healthcare provider. Do not stop taking the medication without consulting them first [1.8.1]. Several strategies can help manage this side effect:
- Dose Adjustment: Your doctor may recommend reducing the dose of leflunomide. For example, a patient on a 20 mg daily dose might be moved to 10 mg daily to see if the symptoms improve [1.3.2].
- Taking with Food: Administering leflunomide with food can sometimes help prevent or ease stomach upset and diarrhea [1.2.3].
- Hydration: It's crucial to stay hydrated by drinking plenty of water or electrolyte-containing sports drinks to replace lost fluids [1.3.3].
- Over-the-Counter (OTC) Medications: For mild cases, your doctor may approve the use of OTC anti-diarrheal medications like loperamide (Imodium) or kaopectate [1.3.1]. Always consult your doctor or pharmacist before taking new medications.
- Medical Evaluation: If diarrhea is severe, persistent, or accompanied by blood, severe abdominal pain, or significant weight loss, it requires immediate medical attention. Your doctor will need to rule out other causes, such as infection or drug-induced colitis [1.2.5].
When Discontinuation is Necessary
In cases of severe or intolerable side effects, or if drug-induced colitis is diagnosed, discontinuing leflunomide may be necessary [1.2.5]. Because leflunomide's active metabolite has a very long half-life and can stay in the body for up to two years, a special "washout" procedure may be required to eliminate it from your system more quickly. This typically involves an 11-day course of cholestyramine or activated charcoal [1.3.5, 1.8.2]. This procedure is also essential for women who plan to become pregnant, as leflunomide can cause severe birth defects [1.3.2].
Leflunomide vs. Other DMARDs: A Side Effect Comparison
Leflunomide is often compared to methotrexate, another common DMARD for RA. Both have similar efficacy, but their side effect profiles differ.
Side Effect | Leflunomide | Methotrexate |
---|---|---|
Gastrointestinal | Diarrhea and nausea are very common [1.2.3]. | Nausea and GI complaints are common [1.5.6]. |
Liver Enzymes | Can cause elevated liver enzymes [1.4.6]. | Higher risk of elevated liver enzymes [1.5.2]. |
Hair Loss | Hair loss or thinning is a known side effect [1.2.3]. | Hair loss can also occur [1.5.4]. |
Lung Issues | Rare but serious risk of interstitial lung disease [1.6.2]. | Can also cause pulmonary issues [1.5.2]. |
Blood Counts | Can cause decreased blood cell counts [1.3.2]. | Risk of bone marrow suppression [1.5.4]. |
Overall, the choice between leflunomide and methotrexate often depends on the individual patient's tolerance and pre-existing conditions [1.5.5].
Conclusion
Yes, leflunomide can, and frequently does, cause diarrhea. For many, this side effect is mild and temporary, but for others, it can be a persistent and challenging issue. Open communication with your rheumatologist is key to managing this side effect effectively, whether through dose adjustments, supportive care, or, if necessary, discontinuing the drug. Regular monitoring of blood tests for liver function and blood counts is also a critical part of staying safe while on leflunomide therapy [1.7.1].
For more information from an authoritative source, you can visit the American College of Rheumatology's patient information page: Leflunomide (Arava)